Dermatologists weigh in: can a tiny dose of acne drug turn back the clock on aging skin?

NCT ID NCT07296536

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study asks a panel of 15 experienced dermatologists to share their opinions on using very low doses of isotretinoin (a drug usually used for acne) to improve skin texture, reduce pore size, and slow signs of aging. No patients receive treatment; instead, the goal is to create expert guidelines on who might benefit, how to dose the drug safely, and what monitoring is needed. The results will help doctors make informed decisions about this off-label use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISOTRETINOIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Venus Research Center

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.